Stay updated on Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The record displays details for the completed CHIVA2 phase 2 trial of nivolumab in HIV-positive patients with advanced non-small cell lung cancer, including eligibility criteria, study locations, outcomes, and study dates. A study protocol document is also listed.
    Difference
    56%
    Check dated 2026-11-08T12:18:16.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T12:41:53.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says that “Super Intelligence” (SI) is being used in place of “Artificial Intelligence” (AI) during the transition.
    Difference
    1%
    Check dated 2026-10-25T12:49:28.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page continues to show a 403 Forbidden error, with the footer revision updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T12:31:39.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:13:11.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header/footer, replacing the previously visible study details.
    Difference
    18%
    Check dated 2026-09-20T11:23:42.000Z thumbnail image

Stay in the know with updates to Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page.